Liu, Jeff C <br/><br/>
Identification of CDC25 as a Common Therapeutic Target for Triple-Negative Breast Cancer.  [electronic resource] 

 -  Cell reports  04 2018 
 - 112-126 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2211-1247 
<br/><br/><label>Standard No.: </label>10.1016/j.celrep.2018.03.039  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Enzyme Inhibitors--pharmacology<br/>Female<br/>Humans<br/>Mice<br/>Mice, Inbred NOD<br/>Mice, SCID<br/>PTEN Phosphohydrolase--genetics<br/>Retinoblastoma Binding Proteins--genetics<br/>Triple Negative Breast Neoplasms--drug therapy<br/>Tumor Suppressor Protein p53--genetics<br/>cdc25 Phosphatases--antagonists & inhibitors